中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
9期
201-202
,共2页
硫酸镁%低分子肝素钙%治疗%肺源性心脏病
硫痠鎂%低分子肝素鈣%治療%肺源性心髒病
류산미%저분자간소개%치료%폐원성심장병
Magnesium sulfate%Low-molecular-weight heparin calcium%Treatment%Pulmonary Heart Disease
目的:对硫酸镁联合低分子肝素钙治疗肺源性心脏病的临床效果进行探讨分析。方法选取于2014年4月~2014年12月在我院心内科进行治疗的42例肺源性心脏病患者,根据治疗方法的不同将患者随机分为两组,对照组患者给予常规治疗,治疗组患者在常规治疗的基础上给予硫酸镁联合低分子肝素钙进行治疗,对比两组患者的治疗效果。结果治疗组患者的治疗总有效率显著高于对照组,并且治疗组患者的PaO2,值显著高于对照组,PaCO2值显著低于对照组,两组数据对比差异显著,有统计学意义(P<0.05)。结论采用硫酸镁联合低分子肝素钙治疗肺源性心脏病具有显著的临床效果,值得在临床治疗中推广使用。
目的:對硫痠鎂聯閤低分子肝素鈣治療肺源性心髒病的臨床效果進行探討分析。方法選取于2014年4月~2014年12月在我院心內科進行治療的42例肺源性心髒病患者,根據治療方法的不同將患者隨機分為兩組,對照組患者給予常規治療,治療組患者在常規治療的基礎上給予硫痠鎂聯閤低分子肝素鈣進行治療,對比兩組患者的治療效果。結果治療組患者的治療總有效率顯著高于對照組,併且治療組患者的PaO2,值顯著高于對照組,PaCO2值顯著低于對照組,兩組數據對比差異顯著,有統計學意義(P<0.05)。結論採用硫痠鎂聯閤低分子肝素鈣治療肺源性心髒病具有顯著的臨床效果,值得在臨床治療中推廣使用。
목적:대류산미연합저분자간소개치료폐원성심장병적림상효과진행탐토분석。방법선취우2014년4월~2014년12월재아원심내과진행치료적42례폐원성심장병환자,근거치료방법적불동장환자수궤분위량조,대조조환자급여상규치료,치료조환자재상규치료적기출상급여류산미연합저분자간소개진행치료,대비량조환자적치료효과。결과치료조환자적치료총유효솔현저고우대조조,병차치료조환자적PaO2,치현저고우대조조,PaCO2치현저저우대조조,량조수거대비차이현저,유통계학의의(P<0.05)。결론채용류산미연합저분자간소개치료폐원성심장병구유현저적림상효과,치득재림상치료중추엄사용。
Objective Clinical ef ect of magnesium sulfate combined with low-molecular-weight heparin calcium in treatment of pulmonary heart disease is to be discussed and analyzed. Methods Choose 42 patients of pulmonary heart disease who are treated in hospital from April 2014 to December 2014 and separate them into two groups according to dif erent treatment approaches. Patients in control group are given conventional treatment,while patients in study group are given magnesium sulfate combined with low-molecular-weight heparin calcium treatment in addition to conventional treatment. And then compare treatment ef icacy between two groups. Results The comparison result shows that treatment ef iciency in study group is much higher than that in control group,and in addition,patients’PaO2, value is higher than counterpart in control group,but PaCO2 value is lower than that in control group;there is a treatment dif erential between the two groups, and such a dif erential has statistic value(P<0.05). Conclusion Magnesium sulfate combined with low-molecular-weight heparin calcium is of clinical ef icacy in treatment of pulmonary heart disease,which is quite worthwhile to be promoted and applied clinical y.